What is Semax made from?

Semax is a synthetic seven-amino-acid peptide (MEHFPGP) built in a laboratory. It is based on a fragment of the naturally occurring stress hormone ACTH (adrenocorticotropin), specifically the 4–10 fragment, with a small Pro-Gly-Pro tail added to improve its stability and duration of action in the body.

Has Semax been tested in humans?

Semax is approved as a stroke medication in Russia and has been used clinically there for years. However, large, rigorous, placebo-controlled trials in healthy humans are still lacking. Most published mechanistic research comes from rodent models and cell-culture experiments, so extrapolating those findings to human use requires caution.

How might Semax affect brain chemistry?

Animal research suggests Semax can raise serotonin metabolite levels in the striatum and modulate dopamine release under certain conditions. It also appears to switch on genes for neuroprotective proteins like BDNF and NGF after ischemic brain injury. These combined effects may underlie its reputation as a nootropic, though human data confirming this are limited.

Is there Alzheimer's research on Semax?

Yes, at an early stage. A 2022 laboratory study found that Semax binds copper ions and inhibits amyloid-beta protein from forming the toxic fiber structures linked to Alzheimer's disease — at least in artificial membrane models. This is chemistry-level research, not a clinical finding, and much more work is needed before any conclusions can be drawn about human disease.

Semax Peptide: Research, Evidence & Dosage Guide

What Exactly Is Semax?

Semax is a synthetic heptapeptide — that just means a tiny chain of seven amino acids built in a lab. It was designed in Russia as an analogue of ACTH(4-10), a fragment of the body's own stress hormone adrenocorticotropin. Scientists tweaked the natural fragment to make it more stable and longer-lasting in the body. The full sequence reads Met-Glu-His-Phe-Pro-Gly-Pro, which is why you'll sometimes see it written as MEHFPGP.

Researchers classify it as a nootropic peptide — nootropic just means it may support brain function. Because it is a peptide (a small protein), it cannot simply be swallowed as a pill; the stomach would digest it. That is why most research protocols use nasal drops or injections.

Want to jump straight to quantities used in research protocols? See our Semax dosage chart, or plug numbers into the calculator.

What Are Researchers Studying It For?

1. Spinal Cord Injury Recovery

A 2025 study published in the British Journal of Pharmacology used a mouse model of spinal cord injury (SCI). Researchers found that Semax improved movement recovery in female mice after a spinal cord impact. How? The peptide appeared to target the μ-opioid receptor, which then triggered a cascade that reduced cell death inside the spinal cord. Specifically, it lowered a damaging process called lysosomal membrane permeabilization — think of it as stopping the cell's own recycling machinery from leaking acid onto healthy tissue.^[1] This is early-stage animal research, but the mechanism identified is genuinely novel.

2. Stroke and Brain Ischemia

When the brain is starved of blood (ischemia), neurons die quickly. A 2010 study found that Semax boosted the transcription — meaning it switched on the genes — of several neurotrophins after a simulated stroke in rats.^[6] Neurotrophins are proteins the brain uses to keep neurons alive and help them repair. Notably, BDNF and NGF — two of the most studied neuroprotective proteins — were among those upregulated. Semax is already approved as a stroke treatment in Russia, though its regulatory status differs in other countries.

3. Dopamine and Serotonin Activity

How might Semax support cognitive function at the chemical level? A 2005 rodent study measured neurotransmitters directly in brain tissue. Semax raised serotonin metabolite levels in the striatum by around 25% within two hours.^[5] The striatum is a brain region involved in mood, motivation, and learning. The same study found that Semax amplified dopamine release when given alongside amphetamine, suggesting it modulates — rather than directly triggers — the dopamine system.

4. Alzheimer's-Related Protein Clumping

One hallmark of Alzheimer's disease is amyloid-beta (Aβ) protein clumping into toxic fibers in the brain. Copper ions make this clumping worse. A 2022 lab study tested whether Semax could interfere with this process. The results showed that Semax binds copper ions and physically blocks Aβ from forming the toxic fiber structures — at least in artificial membrane models.^[4] This is very early-stage chemistry research, not a clinical finding, but it opens an interesting avenue.

5. Developmental and Behavioral Effects

A 2021 rat study looked at an unusual question: what happens when newborn rats are exposed to an antidepressant (fluvoxamine, an SSRI) during a critical brain-development window? The young rats showed anxiety, poor learning, and altered brain chemistry. When Semax was given afterward, it reduced anxiety-like behavior, improved learning, and helped normalize brain monoamine levels.^[3] Monoamines include serotonin, dopamine, and norepinephrine — the core chemical messengers of mood and attention.

6. Broader Orthopedic and Neuroplasticity Interest

A 2026 review in the Journal of the American Academy of Orthopaedic Surgeons grouped Semax alongside other neuroactive peptides, noting its ability to enhance BDNF and related pathways critical to neuroplasticity — the brain's ability to rewire itself.^[2] The authors also flagged an important caveat: preclinical data are promising, but large, well-controlled human clinical trials are still largely absent.

What Does the Evidence Actually Show — and What Doesn't It Show?

Let's be honest about the state of the science. Most Semax studies are done in rodents or in cell cultures. Animal results do not automatically translate to humans. There are no large-scale randomized controlled trials in healthy humans proving cognitive benefits. What researchers have established is a plausible set of mechanisms — opioid receptor signaling, neurotrophin gene activation, monoamine modulation, and anti-aggregation effects — that make Semax interesting enough to keep studying.

This content is for research and educational purposes only and is not medical advice. Always consult a qualified healthcare professional before considering any peptide protocol.

Curious About Research Dosing Ranges?

If you're exploring the published literature on research protocols, our Semax dosage chart breaks down the amounts and routes used across studies. You can also use the calculator to convert between units quickly.

Sources

Semax peptide targets the μ opioid receptor gene Oprm1 to promote deubiquitination and functional recovery after spinal cord injury in female mice. — British journal of pharmacology, 2025. PMID 40692165.
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. — Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews, 2026. PMID 41490200.
Semax, synthetic ACTH(4-10) analogue, attenuates behavioural and neurochemical alterations following early-life fluvoxamine exposure in white rats. — Neuropeptides, 2021. PMID 33418449.
Semax, a Synthetic Regulatory Peptide, Affects Copper-Induced Abeta Aggregation and Amyloid Formation in Artificial Membrane Models. — ACS chemical neuroscience, 2022. PMID 35080861.
Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents. — Neurochemical research, 2005. PMID 16362768.
Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia. — Cellular and molecular neurobiology, 2010. PMID 19633950.

Semax Peptide: What It Is and What Research Shows